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Abstract
Background: Despite major developments in the management of septic shock, the mortality rate
had progressively increased. Ibuprofen has been shown to have beneficial physiological effects when
used as a treatment. However, there are conflicting results with respect to survival. This study aims
to investigate the effect of ibuprofen on vital functions, various physiological parameters and
survival during endotoxic shock in rabbits.
Methods: Twenty-eight New Zealand rabbits were randomly separated into four groups. The first
group received only saline, the second was given 2 mg/kg intravenous endotoxin at t0, the third
received 30 mg/kg ibuprofen 30 minutes after endotoxin administration, whilst the fourth group
received ibuprofen 30 minutes before the endotoxin. Respiratory and heart rate, mean arterial
blood pressure and rectal temperature were recorded. Complete blood counts were performed
and thromboxane B2 was measured every 30 minutes for the first two hours, and then hourly over
the course of the experiment. Urine samples were collected at the same time points for the
measurement of prostaglandin E2.
Results: Ibuprofen was found to improve respiratory rate, heart rate, and arterial pressure.
However, it did not improve the negative effects of endotoxin on body temperature, haematocrit
values, white blood cell count, and thrombocyte number. Thromboxane B2 levels in group IV were
significantly lower than in the other groups, and the increase started at a later timepoint. In
ibuprofen-treated animals, Prostaglandin E2 levels stayed low for at least 90 minutes, but started to
rise thereafter. While the average survival in Group II animals was 192.9 ± 46.9 minutes, those of
groups III and IV were 339.1 ± 33.5 minutes (p < 0.05) and 383.0 ± 39.6 minutes (p = 0.01),
respectively.
Conclusions:  Ibuprofen appears to increase survival in endotoxic shock-induced animals.
Therefore, it may be helpful for the prophylaxis and treatment of patients with, or who are likely
to develop, septic shock.
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Background
Although there have been major developments in its diag-
nosis and treatment, the mortality rate of septic shock has
progressively increased over the past few decades. The
mortality rate can be as high as 60–70% in cases with mul-
ti-organ failure [1], and several pharmacological agents
have been used in an effort to reduce this percentage [2].
In endotoxic shock, bacterial endotoxin enters the system-
ic circulation and triggers the release of pro-inflammatory
mediators. Prostaglandin is released during inflammatory
reactions, causing an increase in microvascular hydrostat-
ic pressure, which is a primary cause of edema and a con-
tributory factor in hypovolemia [3,4].
Non-steroidal anti-inflammatory agents (NSAIDs), such
as acetyl salicylic acid and indometasin, have been used in
the treatment of sepsis and septic shock, and an improve-
ment in survival has been noted. Several researchers have
also evaluated ibuprofen, and beneficial effects on patho-
physiological changes have been observed [3]. The first
major study of ibuprofen in endotoxic shock was per-
formed by Jacobs et al.[5]. This study indicated that ibu-
profen can limit the degree of hypotension and acidosis,
and decrease the cardiac index in endotoxic shock. Fink et
al. [6] reported that ibuprofen restored the normal hemo-
dynamic pattern. However, Hulton et al. [7] saw no major
metabolic effect in E. coli sepsis. Coran et al.[8] showed
that the administration of ibuprofen in septic shock in
dogs did not reduce cytokine levels. Herbertson et al.[9]
showed that ibuprofen administration in endotoxic shock
in pigs could prevent the early hemodynamic changes fol-
lowing entotoxemia, but not the later changes. Bernard et
al. [10] reported that, in patients with sepsis, treatment
with ibuprofen reduced levels of prostacylin and throm-
boxane and decreased fever, tachycardia, oxygen con-
sumption, and lactic acidosis, but did not prevent the
development of shock or acute respiratory distress syn-
drome, and did not improve survival.
Despite several studies using ibuprofen in endotoxic and
septic shock models, there are some conflicting results
with respect to survival, and there are few studies using
pre-treatment with ibuprofen. In this study, we investigat-
ed the effects of ibuprofen on physiological parameters
and survival in pre- and post-treated rabbits with experi-
mentally induced endotoxic shock.
Methods
Preparation of animals
Twenty-eight New Zealand rabbits were anaesthetized by
intramuscular (I.M.) injection with 35 mg/kg ketamin hy-
drochloride (Ketalar ampul, 50 g/ml, Eczacibasi Drug
Company, Istanbul, Turkey) and 5 mg/kg xylasine hydro-
chloride (Rompun ampul, 23.32 mg/ml, Bayer, Istanbul,
Turkey). Anesthesia was maintained with additional dos-
es of ketamin and xylasine. 24 G canulas were inserted in
to the right femoral artery and vein and monitored with a
Siemens SC 6000 monitor (Danvers, MA, USA).
Study Design
The rabbits were randomly divided into four groups of
seven animals. In Group I (control), 1 mL isotonic saline
was given by intravenous infusion and 1 mL blood sam-
ples (to obtain basal vital measurements and biochemical
parameters) were taken simultaneously at 0, 30, 60, 90,
120, 180, and 240 minutes. The rabbits in Groups II, III
and IV (study groups) received 1 mL sterile saline at 30
minute intervals for 120 minutes, after which the sam-
pling and injection frequency was increased to every 60
minutes. Sterile saline was given to Group I for the dura-
tion of the experiment, including at t0. Group II received
2 mg/kg endotoxin (Escherichia coli O55:B5, Sigma Chem-
ical Company, USA) in sterile physiological saline (0.5
mL/kg) at t0. Sodium salt of ibuprofen (Sigma Chemical
Company, USA) was dissolved in sterile saline at 77°C in
a hot water bath. It was cooled down to 35–37°C, then in-
jected into Groups III and IV by slow infusion at a dose of
30 mg/kg/5 mL at +30 and -30 minutes, respectively. Rab-
bits in the first group were followed for 240 minutes, and
those in the remaining groups were followed until they
died.
Measurements
Complete blood counts (CBC) were measured with an
S+Coulter Counter (Fullerton, CA, USA). Blood samples
for measuring Thromboxane B2 (TxB2) levels were collect-
ed in EDTA-tubes, centrifuged at 2000 rpm for 20 min-
utes, and immediately stored at -20°C. Urine samples
were collected for Prostaglandin E2 (PGE2) measurements
by suprapubic aspiration, which completely emptied the
bladder. The urine samples were immediately stored at -
20°C. TxB2 and PGE2 were determined by radioimmu-
noassay according to the manufacturer's protocol (Amer-
sham Pharmacia Biotech Ltd, UK) using the Amerlex-M
Magnetic Separation System at the Department of Bio-
chemistry, College of Medicine, Istanbul University. Rec-
tal temperatures were taken with a thermometer.
Statistical Analysis
All data are presented as mean ± SEM. Parameters were
compared over the study period using analysis of variance
for repeated measures (SPSS version 10.01 for Windows).
Where the F values were found to be significant, data were
compared with Tukey's b test. Comparisons between the
four groups at the same time point were analyzed by one-
way analysis of variance followed by Tukey's-b post hoc
test, where appropriate. P < 0.05 was considered statisti-
cally significant.BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/26
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Results
Respiratory rate, heart rate, mean arterial blood pressure
(MAP), body temperature, leukocyte and platelet counts,
haematocrit levels, plasma TxB2 and urine PGE2 levels in
all groups are discussed below. None of the rabbits in
Group I died after the experiment. The letter 'N' in Tables
1,2,3 indicates the number of rabbits that survived endo-
toxin administration in the study groups.
Respiratory rate
This was significantly increased over 30, 60, 90 and 120
minutes in group II (p < 0.001). In comparison, it was
high at 30 minutes, but returned to t0 levels after 60 min
in group III rabbits.
The respiratory rate in Group IV was increased compared
to the control group (Group I), but this difference was not
statistically significant (p > 0.05). This parameter in both
Groups III and IV was lower than in Group II (p < 0.001).
There was no significant difference in respiratory rate be-
tween Groups III and IV (p > 0.05, Table 1 and Fig. 1).
Heart rate
In Group II rabbits, which received endotoxin, heart rates
significantly increased between 30 and 90 minutes, com-
pared to t0 (p < 0.001).
Group III received endotoxin and ibuprofen at 0 and 30
minutes, respectively. In this group, heart rates were
found to be increased at 30 and 60 minutes compared to
t0 (p > 0.05). In this group, only one rabbit survived after
420 minutes.
Ibuprofen was administered to Group IV at 30 min and
endotoxin at t0. An increase in heart rate was observed at
60 minutes, but this was not statistically significant (p >
0.05).
When all groups were compared, heart rates at 60 min in
both Groups II and III were significantly higher than in
Group I (p < 0.05). Heart rates in Group IV were not sig-
nificantly different from the control group (p > 0.05), but
were significantly lower than both Groups II and III (p <
0.01, Table 2 and Fig. 2).
Mean arterial pressure
MAP levels showed an obvious decrease at 30 minutes in
group II, which received only endotoxin from t0. MAP lev-
els gradually decreased in group III, but showed a more
regular gradual decrease in group IV.
When MAP levels between the groups were compared, it
was observed that groups II and III had statistically signif-
icant decreases compared to groups I and IV (p < 0.0001)
at 30 minutes. Although MAP values decreased in group
IV, there was an obvious difference between groups IV and
I (p > 0.05).
At 60 minutes, MAP levels started to decrease in group IV,
and were statistically different from groups III and I (p <
0.01). At 90 minutes, MAP levels in groups II and IV re-
Table 1: Respiratory rate changes over time for each group
Time (min) Respiratory Rate (/min, mean ± SEM)
Group I N Group II N Group III N Group IV N
-30 64.6 ± 5.3 7
0 39.6 ± 3.1 7 52. 9 ± 3.0 7 68.7 ± 5.3 7 62.1 ± 4.2 7
30 39.9 ± 3.5 7 96.1 ± 8.7 7 125.3 ± 9.4 7 68.0 ± 6.4 7
60 42.1 ± 4.8 7 97.5 ± 4.6 6 73.4 ± 5.4 7 55.0 ± 8.3 7
90 39.7 ± 4.8 7 95.3 ± 6.4 6 71.6 ± 6.0 7 68.0 ± 11 7
120 38.6 ± 4.2 7 92.6 ± 58.4 5 72.9 ± 6.9 7 73.4 ± 3.1 7
180 37.1 ± 3.9 7 56.4 ± 50.6 5 78.8 ± 6.9 7 70.4 ± 8.0 7
240 79 4 . 0   ± 11.0 3 79.6 ± 6.0 7 67.7 ± 12.8 7
300 7 115.0 1 67.0 ± 12.8 6 71.3 ± 12.0 7
360 4.0 1 86.5 ± 27.5 2 53.3 ± 19.9 3
420 112.0 1 84.0 1
480 54.0 1 76.0 1
540 100.0 1
600 103.0 1
N: number of rabbits that survived endotoxin administrationBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/26
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mained statistically different from groups I and III (p <
0.01). At 120 minutes, they started to decrease in group III
and statistically clear differences from group I (p < 0.05)
could be seen. Arterial pressure in group III was found to
be statistically higher than in both groups II and IV (p <
0.02). At 180 and 240 minutes, MAP levels kept decreas-
ing in groups II, III and IV. They were clearly lower in
those three groups than in group I (p < 0.001, Table 3 and
Fig. 3).
Body temperature
In general, there was no statistically significant difference
in body temperature between the study groups, but there
was a significant difference between Group I and the study
groups (p < 0.001). In addition, hypothermia developed
after endotoxin administration.
White blood cell count
There were fewer white blood cells in the study groups
than in the control group, and the difference was statisti-
cally significant (p < 0.0001). There was no significant dif-
ference in white blood cell counts between the endotoxin-
and ibuprofen-treated groups.
Platelet count
The number of platelets decreased after endotoxin admin-
istration, but ibuprofen had no effect on the platelet
counts.
Figure 1
Mean respiratory rate values change over time for all groups. In both Groups III and IV, respiratory rates were lower
than in Group II (p < 0.001). No significant difference was seen between Groups III and IV (p > 0.05).
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Haematocrit levels
These began to decrease gradually after 90 min in group II,
and after 180 min in group III (when they were signifi-
cantly lower than the onset levels). In group IV there were
no statistically significant changes in haematocrit values
throughout the study.
Plasma TxB2 levels
These increased following administration of endotoxin at
t0 in Group II. Significant decreases in TxB2 levels were de-
tected in Group III from 60 to 240 min, after injection of
ibuprofen at 30 min. Highly significant differences were
observed between the t0 and 240 min samples (p <
0.001).
In Group IV, plasma TxB2 levels were lowest between -30
minutes and t0 (there was no significant difference be-
tween them). Plasma TxB2levels began to increase after 30
minutes, which was significantly different from the -30
minute and t0 values (p < 0.005 and p < 0.01, respective-
ly).
When plasma TxB2 levels were compared between all
groups, t0 values were not significantly different between
Groups II and III (p > 0.05), but they were significantly
lower in Group IV than in any of the other groups (p <
0.006).
Figure 2
Mean Heart rate values change over the time for all groups. In groups II and III, heart rates at 60 min were significantly
higher than in Group I (p < 0.05). In Group IV they were not significantly different from controls (p > 0.05), but lower than II
and III (p < 0.01).
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At 60 minutes, plasma TxB2 levels were reduced in both
Groups II and III, but were increased in Group IV. They
were significantly different between Groups II and III and
the control group, but no significant differences were de-
tected between study groups (p > 0.05, Table 4 and Fig. 4).
Urine PGE2 levels
These increased transiently after 30 minutes in Group II,
and the increase at 60 min was significantly different from
the 90 min sample. In Group III, urine PGE2 levels were
significantly increased at 30 min compared with t0 (p <
0.001). However, they declined after 60 minutes. This de-
cline continued to the 90 minute sample, so that PGE2
levels at both 60 and 90 min were significantly lower than
the 30 minute value (p < 0.001), but no different from t0
(p > 0.05). In Group IV, PGE2 levels increased at 30 min
compared to t0, after administration of endotoxin. They
then began to decrease from 60 and 120 min, but the dif-
ference was only significant between 30 and 90 min (p <
0.025, Table 5 and Fig. 5).
Survival rates
Among the three endotoxic shock groups, the longest
mean survival time was observed in Group IV (383.0 ±
Figure 3
Mean arterial blood pressure changes over time for each group. At 60 minutes, MAP levels started to decrease in
group IV, and were statistically different from groups III and I (p < 0.01). At 90 minutes, MAP levels in groups II and IV remained
statistically different from groups I and III (p < 0.01). At 120 minutes, they started to decrease in group III and statistically clear
differences from group I (p < 0.05) could be seen. Arterial pressure in group III was found to be statistically higher than in both
groups II and IV (p < 0.02). At 180 and 240 minutes, MAP levels kept decreasing in groups II, III and IV. They were clearly lower
in those three groups than in group I (p < 0.001).
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39.0 minutes). The survival rate in Group IV was signifi-
cantly higher than in Group II (192.9 ± 46.9 minutes), but
not significantly higher than Group III (339.1 ± 33.5 min-
utes) (p > 0.05). In Group III, mean survival time was also
significantly higher than in Group II (p < 0.05). Mean sur-
vival times are shown in Fig. 6.
Discussion
Ibuprofen is a reversible, short-acting cyclooxygenase in-
hibitor, which particularly blocks the synthesis of throm-
boxane. Under in vitro conditions, it has been shown that
ibuprofen stabilizes lyszomal membranes, restrains the
secretion of lysozomal enzymes from granulocytes, and
prevents the aggregation of platelets as well as the immi-
gration of leukocytes [1–5].
NSAIDs were first used by Northover and Subramanian
[11] in an endotoxic shock model in dogs, in order to im-
prove hemodynamic disorders. In endotoxic or septic
shock models, respiration pathway changes occur in the
lungs. Metabolites of cyclooxygenase play an important
role in this. Studies done with ARDS patients have shown
that there is an increase in the number of PMNs in the
lung and bronco-alveolar fluid, which cause an increase in
elastase and other lysozomal enzymes [12]. Kopolovic et
al.[13] have reported that respiration dysfunction and hy-
Figure 4
Mean Plasma TxB2 values over time for all groups. Plasma TxB2 t0 values were not significantly different between
Groups II and III (p > 0.05), but they were significantly lower in Group IV than in any of the other groups (p < 0.006). At 60
minutes, plasma TxB2 levels were reduced in both Groups II and III, but were increased in Group IV. They were significantly
different between Groups II and III and the control group, but no significant differences were detected between any of the
study groups (p > 0.05)
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poxemia were improved and pulmonary hypertension de-
creased in pigs that were administered ibuprofen after
Pseudomonas aeruginosa infusion. In addition, the same re-
searchers reported that treatment with ibuprofen caused a
decrease in pulmonary shunt and lung edema. Balk et al.
[14] used ibuprofen in a canine endotoxic shock model
and found that it affected the extent of histological and
morphometric lung injury.
In this study, the respiratory rates of the study groups were
significantly higher than the control group at 30 min. The
respiration rates in both Groups III and IV were lower
than in Group II right out to 360 minutes. Because the
study groups (II, III, and IV) showed no remarkable differ-
ences after 360 min, we presume that ibuprofen is not ef-
fective after this time. In addition, ibuprofen
administration can prevent hyperpnoea if given before en-
dotoxin.
Endotoxin administration may lead to hypotension and
tachycardia [1]. In one study, Suffredini et al.[15] admin-
istered endotoxin to healthy volunteers and observed an
increase in cardiac output of 53%, a decrease in systemic
vascular pressure of 46% and an increase in heart rate of
Figure 5
Mean Urine PGE2 values over time for all groups. In Group III, urine PGE2 levels were significantly increased at 30 min
compared with t0 (p < 0.001). They declined after 60 minutes and continued to decline at 90 minutes; levels at both 60 and 90
min were significantly lower than the 30 minute value (p < 0.001), but no different from t0 (p > 0.05). In Group IV, PGE2 levels
increased at 30 min compared to t0, then began to decrease from 60 and 120 min, but the difference was only significant
between 30 and 90 min (p < 0.05).
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36%. Previously, it has been observed that ibuprofen ad-
ministration in endotoxic shock models prevents an in-
crease in heart rate due to metabolic changes or regulation
of oxygen dispersal at the tissue level [16,17]. In addition,
another study by Revhaug et al.[18] reported that ibupro-
fen administration before endotoxin prevented an in-
crease in heart rate. Yamanaka et al.[19] reported that
there were no significant differences from the heart rates
of controls in a similar study.
In our study, it was observed that pre-treatment with ibu-
profen prevented heart rate increase. The effects of ibupro-
fen started at 90 min and lasted up to 180 min in the
group that received ibuprofen after endotoxin. Thus, it ap-
pears that ibuprofen has no effect on secreted cyclooxyge-
nase products, as it inhibits the cyclooxygenase enzyme.
With this inhibition, new production of cyclooxygenase
products is blocked. Therefore, the cyclooxygenase secret-
ed by Group III caused tachycardia, but new formation of
cyclooxygenase was inhibited by ibuprofen administra-
tion, so tachycardia was resolved. Therefore, it seems that
ibuprofen administration has little effect on respiratory
rate and heart rate.
Beck and Abel [20] reported that administration of ibu-
profen before endotoxin blocked the sudden drop in
mean arterial pressure in experimentally-induced endo-
toxic shock in dogs. Coran et al.[8] reported that mean ar-
terial pressure was significantly higher in animals that
received ibuprofen before induced shock than the control
Figure 6
Mean Survival times over time for all groups. In Group IV survival rate was significantly higher than in Group II, but not
higher than Group III (p > 0.05). In Group III, mean survival time was also higher than in Group II (p < 0.05).
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group in their experimental canine septic shock model.
They indicated that MAP was consistently about 90% of
the initial arterial pressure level. They also reported that
when animals received ibuprofen after endotoxin; arterial
pressure initially fell to about 50%, then increased gradu-
ally and continued to be about 70% of initial levels.
In the present study, there was a general reduction in
mean arterial blood pressure in group II, which received
endotoxin. On the other hand, there was a sudden drop in
MAP in Group IV, which received ibuprofen before endo-
toxin, whereas an increase in MAP was seen at 60 minutes
in the group that received ibuprofen after endotoxin.
Table 2: Heart rate changes over time for each group
Time (min) Heart Rate (/min, mean ± SEM)
Group I N Group II N Group III N Group IV N
-30 177.8 ± 3.8 7
0 181.6 ± 4.9 7 172.7 ± 4.4 7 184.0 ± 1.9 7 168.1 ± 4.3 7
30 175.7 ± 4.3 7 240.4 ± 12.6 7 239.6 ± 9.4 7 184.7 ± 9.3 7
60 175.6 ± 6.0 7 227.2 ± 8.6 6 222.4 ± 15.1 7 164.8 ± 11.3 7
90 176.1 ± 5.2 7 227.8 ± 8.5 6 184.6 ± 4.9 7 174.7 ± 6.3 7
120 173.8 ± 5.7 7 190.0 ± 30.2 5 182.4 ± 4.9 7 174.1 ± 5.1 7
180 178.1 ± 5.3 7 149.2 ± 30.2 5 200.6 ± 24.5 7 151.6 ± 10.4 7
240 177.6 ± 6.0 7 84.3 ± 49.6 3 184.6 ± 25.6 7 153.1 ± 19.2 7
300 7 174.0 1 159.0 ± 14.1 6 126.1 ± 17.0 7
360 155.0 1 175.5 ± 24.5 2 139.3 ± 42.8 3
420 176.0 1 169.0 1
480 145.0 1 156.0 1
540 151.0 1
600 128.0 1
N: number of rabbits that survived endotoxin administration
Table 3: Mean arterial pressure changes over time for each group
Time (min) Mean Arterial Blood Pressure (mmHg, mean ± SEM)
Group I N Group II N Group III N Group IV N
-30 74.2 ± 1.9 7
0 69.3 ± 4.8 7 70.1 ± 3.1 7 66.4 ± 3.1 7 73.3 ± 3.5 7
30 66.9 ± 4.5 7 29.0 ± 2.6 7 40.1 ± 6.9 7 62.4 ± 5.0 7
60 65.8 ± 4.0 7 32.9 ± 1.1 6 59.7 ± 7.1 7 45.9 ± 16.8 7
90 71.9 ± 6.0 7 31.3 ± 5.2 6 63.8 ± 6.5 7 41.8 ± 4.0 7
120 75.9 ± 6.0 7 36.5 ± 7.2 5 59.8 ± 3.5 7 44.3 ± 4.1 7
180 79.9 ± 4.7 7 28.9 ± 9.9 5 49.2 ± 5.4 7 32.5 ± 2.8 7
240 73.2 ± 4.9 7 29.2 ± 14.4 3 46.3 ± 3.7 7 28.5 ± 1.4 7
300 71 1 . 0 13 9 . 7   ± 5.4 6 16.9 ± 1.5 7
360 8.0 1 34. ± 3.0 2 24.6 ± 3.9 3
420 34.7 1 40.7 1
480 25.0 1 29.7 1
540 32.4 1
600 25.6 1
N: number of rabbits that survived endotoxin administrationBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/26
Page 11 of 13
(page number not for citation purposes)
However, since initial MAP levels were not established in
the study groups, it is possible that some other mediators
were affecting blood pressure at the start of the experi-
ment.
Ebong et al.[21] reported that all mice developed hypo-
thermia in their model, where septic shock was induced
by caecal ligation. While body temperature was above
34°C on day 1, it later decreased below 34°C. Haupt et
al.[22] observed that fever in severe septic shock patients'
was reduced after ibuprofen administration. However,
they did not see a reduction in PGE2 levels, so they as-
sumed that the reduction in fever was due to ibuprofen
causing a decrease in IL-1 and TNF secretion, or due to the
direct effect of ibuprofen on the central nervous system.
The anti-pyretic effect of ibuprofen started at 4 hours, and
lasted up to 24 hours after infusion.
The role of cytokines in hypothermia is not yet known,
however, it is thought that the decrease in body tempera-
ture is dependent on a decrease in pyrojenic cytokines.
During hypothermic sepsis, the response of cytokines and
eicosanoids is higher than in febrile patients. Therefore,
ibuprofen has been considered to be more useful in hypo-
thermic patients than in septic shock patients [23]. In our
study, changes in body temperature among study groups
were not statistically significant.
The numbers of white blood cells are reduced in experi-
mental animals induced with endotoxic shock [24]. Grif-
fin et al.[4] reported that the number of white blood cells
decreased after endotoxin administration in pigs. In addi-
tion, they found significant differences between endotox-
in and endotoxin plus ibuprofen administration. In our
study groups, the numbers of white blood cells were sig-
nificantly lower than in the controls (p < 0.0001). There
were, however, no significant differences in the white
blood cell counts between endotoxin and ibuprofen treat-
ed groups.
Haematocrit values appear to increase in some endotoxic
shock models, but decrease in others [10,19,20,22]. It has
been reported that ibuprofen has no effect on the con-
sumption of systemic complement, thrombocytopenia,
leucocytosis or leucopenia [25]. In our study, there was no
increase in haematocrit levels. This may be related to the
fact that 30–35 mL of blood was withdrawn from each
rabbit. Ibuprofen also appeared to have no effect on hae-
matocrit levels in our study.
The occurrence of isolated thrombocytopenia is higher
than 50% in septic shock patients without disseminated
intravascular coagulation [26]. The endotoxic shock ex-
perimentally induced by Griffin et al.[4] in pigs showed
that the numbers of platelets decreased after endotoxin
administration, but no significant differences were again
seen between endotoxin and endotoxin plus ibuprofen (p
> 0.05). In our study, it was also observed that the number
of platelets decreased after endotoxin administration,
whilst ibuprofen had no effect. Many studies have shown
that endotoxin administration can result in an acute de-
crease in the white blood cell count [4,12], but we pro-
pose that ibuprofen has no effect on leukocyte and
platelet counts.
It has been indicated that the pathway of cyclooxygenase
products, such as TxB2 and PGE2, increases in many endo-
toxic shock models and plays an important role in a
number of pathophysiological events [21,27].
TxA2 is a product of arachidonic acid and a potent platelet
aggregator, whose levels increase during endotoxic shock.
Table 4: Plasma TxB2 values over time for each group
Time (min) Plasma TxB2 Levels (ng/mL, mean ± SEM)
Group II Group III Group IV
-30 0.41 ± 0.07
0 1.80 ± 0.29 2.15 ± 0.34 0.54 ± 0.05
30 2.03 ± 0.15 2.00 ± 0.36 1.20 ± 0.10
60 1.85 ± 0.26 1.00 ± 0.35 1.30 ± 0.09
90 2.50 ± 0.55 0.69 ± 0.09 1.50 ± 0.15
120 2.49 ± 0.13 0.67 ± 0.08 1.60 ± 0.18
180 2.12 ± 0.26 0.76 ± 0.08 1.80 ± 0.27
240 1.75 ± 0.29 0.87 ± 0.13 1.60 ± 0.30BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/26
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Ibuprofen prevents the formation of TxA2, as well as plate-
let and leucocyte aggregation [12,21]. Fletcher et al.[28]
reported that the levels of TxB2 were significantly reduced
in rats by a combination of TNF and ibuprofen. Plasma
TxB2 levels were also reduced by introducing ibuprofen
into the faecal peritonitis rat model used by Wise et
al.[29].
In this study, TxB2 levels decreased in the ibuprofen post-
treated group compared with initial onset levels. In addi-
tion, it was found that the onset levels of TxB2 were signif-
icantly lower in the pre-treated group than the other
groups. Making incisions into the rabbits may have
caused an increase in pro-inflammatory cytokines. Low
levels of TxB2 in group IV (at 0–30 min) were probably a
result of ibuprofen inhibiting the increase which would
normally be caused by these cytokines.
The endotoxic shock mouse model reported by Rosello et
al.[30] showed that the levels of PGE2 were significantly
lower in the ibuprofen-treated group than in controls.
However, the levels of urine PGE2 were higher at 12 hours
in both treated and untreated animals, but the difference
was not statistically significant. In our study, it was ob-
served that urine PGE2 gradually increased in group II af-
ter endotoxin administration. After treatment with
ibuprofen, urine PGE2 levels decreased over the next 90
min, but later began to rise again. In another version of
this study published previously, it was seen that ibuprofen
reduced the endothelin production induced by endotoxin
administration [31].
Griffin et al.[4] reported that there was no difference in
mean survival times between control and ibuprofen pre-
and post-treated groups. Arons et al.[23] performed a
study with hypothermic septic patients, and reported that
ibuprofen could be used to decrease mortality rates.
Schirmer et al.[32] found a transient 24-hour survival ben-
efit in a rat model of septic shock. Fletcher et al[3] also re-
ported that TNF-induced mortality could be reduced by
using ibuprofen. Rosello et al.[30] found survival rates in-
creased in mice treated with ibuprofen. In addition,
Young and Passmore [33] reported that ibuprofen-treated
canines with induced endotoxic shock had longer survival
times than those treated with propylgallate. However, Ber-
nard et al.[10] reported that there were no statistically sig-
nificant differences between ibuprofen-treated and
untreated animals with regards to their 30-day survival
rate.
In our study, mean survival time was significantly longer
in the ibuprofen-treated groups compared with the un-
treated group. In addition, the pre-treated group had a
longer mean survival time than the post-treated group,
but it was not statistically significant.
Conclusions
Ibuprofen appears to increase short-term survival due to
its positive effect on various physiological parameters.
Therefore, the use of ibuprofen at higher doses, over long-
er time periods, or in combination with other drugs in pa-
tients who are at risk of developing septic shock could be
effective as a prophylaxis or treatment.
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